PCV54 COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.490
https://www.valueinhealthjournal.com/article/S1098-3015(19)30682-5/fulltext
Section Title :
Section Order :
10135
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30682-5&doi=10.1016/j.jval.2019.04.490